|
Chỉ định và Liều dùng
Oral
Immunosuppressant in renal transplant patients Adult: 1-3 mg/kg daily. Higher doses (>5 mg/kg daily) have been used. Oral Nephrotic syndrome, Rheumatoid arthritis Adult: For nephrotic syndrome associated with primary glomerular disease or lupus nephritis: 50 mg tid.
|
|
Chống chỉ định
Hypersensitivity.
|
|
Thận trọng
Doses must be reviewed regularly in renal transplant patients to ensure that plasma drug level is in the therapeutic range. Monitor serum uric acid regularly during treatment. Increased risk of infections and malignancy. Use with caution in patients with active disorders of the GI tract. Live vaccines should also be avoided.
|
|
Tác dụng không mong muốn
Hyperuricaemia. GI symptoms.
|
|
Tương tác
Increased risk of rhabdomyolysis when used concurrently with bezafibrate.
|
|
Tác dụng
Description:
Mechanism of Action: Mizoribine is an imidazole nucleoside originally isolated from Eupenicillium brefedianum. It is an immunosuppressant that works by blocking the purine biosynthesis pathway and inhibiting mitogen-stimulated T-and B-cell proliferation. Pharmacokinetics: Absorption: Rapidly absorbed from the intestines. Excretion: Almost completely excreted within 24 hr; mainly in urine (85%) and in the bile (1%). |
|
Phân loại MIMS
|
Đăng xuất
